Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.42
+0.10001.37%
Post-market: 7.420.00000.00%16:05 EDT
Volume:30.55K
Turnover:224.53K
Market Cap:43.47M
PE:-0.65
High:7.50
Open:7.38
Low:7.13
Close:7.32
Loading ...
May 12, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 30, 2020

Major Issues Report

Current report, item 5.02
Feb 27, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 01, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Oct 25, 2019

Major Issues Report

Current report, item 5.02
Sep 30, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 12, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]